journal article·2009-06

Novel mesoporous silica-based antibiotic releasing scaffold for bone repair

Xuetao Shi, Yingjun Wang, Li Ren, Naru Zhao, Yihong Gong, Dong-An Wang

Acta Biomaterialia· Volume 5· Issue 5
Publisher page

Abstract

Tissue engineering scaffolds with a micro- or nanoporous structure and able to deliver special drugs have already been confirmed to be effective in bone repair. In this paper, we first evaluated the biomineralization properties and drug release properties of a novel mesoporous silica-hydroxyapatite composite material (HMS-HA) which was used as drug vehicle and filler for polymer matrices. Biomineralization can offer a credible prediction of bioactivity for the synthetic bone regeneration materials. We found HMS-HA exhibited good apatite deposition properties after being soaked in simulated body fluid (SBF) for 7 days. Drug delivery from HMS-HA particle was in line with Fick's law, and the release process lasted 12 h after an initial burst release with 60% drug release. A novel tissue engineering scaffold with the function of controlled drug delivery was developed, which was based on HMS-HA particles, poly(lactide-co-glycolide) (PLGA) and microspheres sintering techniques. Mechanical testing on compression, degradation behavior, pH-compensation effect and drug delivery behavior of PLGA/HMS-HA microspheres sintered scaffolds were analyzed. Cell toxicity and cell proliferation on the scaffolds was also evaluated. The results indicated that the PLGA/HMS-HA scaffolds could effectively compensate the increased pH values caused by the acidic degradation product of PLGA. The compressive strength and modulus of PLGA/HMS-HA scaffolds were remarkably high compared to pure PLGA scaffold. Drug delivery testing of the PLGA/HMS-HA scaffolds indicated that PLGA slowed gentamycin sulfate (GS) release from HMS-HA particles, and the release lasted for nearly one month. Adding HMS-HA to PLGA scaffolds improved cytocompatibility. The scaffolds demonstrated low cytotoxicity, and supported mesenchymal stem cells growth more effectively than pure PLGA scaffolds. To summarize, the data supports the development of PLGA/HMS-HA scaffolds as potential degradable and drug delivery materials for bone replacement.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Bone Tissue Engineering Materials · biodegradable polymer synthesis and properties · Orthopaedic implants and arthroplasty

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (38)

Show source-provided references
1. Novel drug delivery system of hollow mesoporous silica nanocapsules with thin shells: preparation and fluorescein isothiocyanate (FITC) release kinetics10.1016/j.colsurfb.2007.03.005 ↗
2. Mesoporous materials for drug delivery10.1002/anie.200604488 ↗
3. Shi X, Wang Y, Ren L, Gong Y, Wang D-A. Pharm Res. 2009;26:442–30.10.1007/s11095-009-9833-2 ↗
4. The potential of ordered mesoporous silica for the storage of drugs: the example of a pentapeptide encapsulated in a MSU-Tween 8010.1002/cphc.200390045 ↗
5. Lipid-based systems for the enhanced delivery of poorly water soluble drugs10.1016/j.addr.2007.10.009 ↗
6. Histidylated cationic polyorganophosphazene/DNA self-assembled nanoparticles for gene delivery10.1016/j.ijpharm.2007.11.041 ↗
7. Electrospinning: applications in drug delivery and tissue engineering10.1016/j.biomaterials.2008.01.011 ↗
8. Carbon nanotubes as drug delivery nanocapsules10.1016/j.cap.2007.10.011 ↗
9. An ionically crosslinked hydrogel containing vancomycin coating on a porous scaffold for drug delivery and cell culture10.1016/j.ijpharm.2007.11.023 ↗
10. Johnson MR, Lee H-J, Bellamkonda RV, Guldberg RE. Sustained release of BMP-2 in a lipid-based vehicle. Acta Bioamter. doi:10.1016/j.actbio.2008.09.001.10.1016/j.actbio.2008.09.001 ↗
11. From microporous to mesoporous molecular sieve materials and their use in catalysis10.1021/cr960406n ↗
12. Preparation and CO2 separation properties of amine-modified mesoporous silica membranes10.1016/j.micromeso.2006.11.007 ↗
13. Novel mesoporous silicoaluminophosphates as highly active and selective materials in the Beckmann rearrangement of cyclohexanone and cyclododecanone oximes10.1016/j.jcat.2007.09.006 ↗
14. Organo-modified mesoporous silicas for organic pollutant removal in water: solid-state NMR study of the organic/silica interactions10.1016/j.micromeso.2007.06.056 ↗
15. Direct electrochemistry of glucose oxidase immobilized on a hexagonal mesoporous silica-MCM-41 matrix10.1016/j.bioelechem.2006.09.009 ↗
16. Ordered mesoporous and macroporous inorganic films and membranes10.1016/j.memsci.2004.01.019 ↗
17. A new property of MCM-41: drug delivery system10.1021/cm0011559 ↗
18. Adsorption and entrapment of salicylamide molecules into the mesoporous structure of folded sheets mesoporous material (FSM-16)10.1023/A:1023851622676 ↗
19. Mesoporous silica material TUD-1 as a drug delivery system10.1016/j.ijpharm.2006.09.019 ↗
20. Influence of cross-linked PMMA beads on the mechanical behavior of self-curing acrylic cements10.1002/jbm.b.30054 ↗
21. PLGA microsphere/calcium phosphate cement composites for tissue engineering: in vitro release and degradation characteristics10.1163/156856208785540136 ↗
22. Injectable PLGA microsphere/calcium phosphate cements: physical properties and degradation characteristics10.1163/156856206778366004 ↗
23. PLGA/mesoporous silica hybrid structure for controlled drug release10.1016/j.jconrel.2004.04.023 ↗
24. Human endothelial cell growth and phenotypic expression on three dimensional poly(lactide-co-glycolide) sintered microsphere scaffolds for bone tissue engineering10.1002/bit.21495 ↗
25. Amorphous hydroxyapatite-sintered polymeric scaffolds for bone tissue regeneration: physical characterization studies10.1002/jbm.a.31380 ↗
26. Self-assembly of nanohydroxyapatite in mesoporous silica10.1007/s10856-008-3424-3 ↗
27. Biodegradable controlled antibiotic release devices for osteomyelitis: optimization of release properties10.1111/j.2042-7158.1994.tb03890.x ↗
28. How useful is SBF in predicting in vivo bone bioactivity?10.1016/j.biomaterials.2006.01.017 ↗
29. Impact of UV disinfection on microbially available phosphorus, organic carbon, and microbial growth in drinking water10.1016/S0043-1354(02)00462-1 ↗
30. Finish Standards Association. Determination of total phosphorus in water, digestion with peroxidisulfate. SFS 3026. Helsinki: Finish Standards Association SFS, 1986.
31. An alizarin red-based assay of mineralization by adherent cells in culture: comparison with cetylpyridinium chloride extraction10.1016/j.ab.2004.02.002 ↗
32. In vitro cartilage formation of composites of synovium-derived mesenchymal stem cells with collagen gel10.1007/s00441-005-0010-6 ↗
33. Drug self-templated synthesis of ibuprofen/mesoporous silica for sustained release10.1002/ejic.200501035 ↗
34. Influences of material characteristics on ibuprofen drug loading and release profiles from ordered micro- and mesoporous silica matrics10.1021/cm0401490 ↗
35. A simple model framework for the prediction of controlled release from bulk eroding polymer matrices10.1039/b718277e ↗
36. Tissue engineered microsphere-based matrices for bone repair: design and evaluation10.1016/S0142-9612(01)00137-5 ↗
37. Meyer · 2006
38. Composites of poly(latide-co-glycolide) and the surface modified carbonated hydroxyapatite nanoparticles10.1002/jbm.a.31038 ↗